Abstract:Synergistic effects have previously been observed for a natural compound, tetrandrine (TET), with fluconazole (FLC) in vitro and in the treatment of Candida albicans-infected mice. To investigate the mechanisms of these synergistic effects, 16 strains of C. albicans from the same parent but with different FLC sensitivities were examined using flow cytometry and fluorescent spectrophotometry. Rhodamine 123 (Rh 123)-positive cells and intracellular Rh 123 fluorescence intensity were determined in accumulation/efflux experiments involving no or a noncytotoxic dose of TET. Total RNA extracted from each strain was used to compare the expressions of drug efflux pump genes in FLC-susceptible,-susceptible dose-dependent, and -resistant strains before and 24 It after TET administration. Accumulation experiments determined that mean percentages of Rh123-positive cells were 26.65 % (TET-free) and 70.99% (TET 30 mu g/ml), and mean respective intracellular Rh123 fluorescence intensities were 11.34 and 18.00. Efflux experiments showed that percentages of Rh123-positive cells were 1.79% (TET free) and 42.57% (TET 30 mu g/ml), respectively, and respective mean intracellular Rh123 fluorescence intensities were 0.74 and 2.19. Differences in MDR1, FLU1, CDRI, and CDR2 expression levels in the absence of TET were statistically significant (p<0.05) between FLC-susceptible, -susceptible dose-dependent, and -resistant strains. Compared with TET-free conditions, 24 h TET-treated strains showed statistically different (p<0.05) expression of MDR1 (FLC-resistant strain), FLU1 (FLC-susceptible dose-dependent and -resistant strains), and CDR1 and CDR2 (FLC-susceptible, -susceptible dose-dependent, and -resistant strains). Thus TET can inhibit the C. albicans drug efflux system and reduce drug efflux. Its mechanism of action is related to the inhibition of expression of the drug efflux pump genes MDR1, FLU1, CDR1, and CDR2.

In vitro interactions between tetrandrine and ketoconazole against Candida albicans determined by chequerboard method

In Vitro Synergistic Effect of Tetrandrine on Ketoconazole Against Candida Parapsilosis Complex

Synergistic anti-candidal activity of tetrandrine on ketoconazole: an experimental study.

In Vitro Interaction of Itraconazole with Amphotericin B, Caspofungin, and Terbinafine Against Clinical Isolates of Trichosporon asahii

In vitro interactions between tetrandrine and itraconazole against Aspergillus fumigatus determined by the checkerboard method

Synergistic Effects of Tetrandrine on the Antifungal Activity of Topical Ketoconazole Cream in the Treatment of Dermatophytoses: A Clinical Trial

In Vitro Evaluation of the Activity of Tetrandrine Combined with Voriconazole Against Aspergillus Fumigatus by a Checkerboard Method

Synergistic mechanism for tetrandrine on fluconazole against Candida albicans through the mitochondrial aerobic respiratory metabolism pathway.

Differential proteomic analysis of fluconazole-sensitive Candida albicans before and after tetrandrine treatment

The Efflux Pump Inhibitor Tetrandrine Exhibits Synergism with Fluconazole or Voriconazole Against Candida Parapsilosis

Mechanism of action of tetrandrine, a natural inhibitor of Candida albicans drug efflux pumps.

In Vitro Interactions Between Tacrolimus and Azoles Against Candida Albicans Determined by Different Methods.

Tetrandrine Enhances the Antifungal Activity of Fluconazole in a Murine Model of Disseminated Candidiasis.

Molecular Mechanisms Underlying the Tetrandrine-Mediated Reversal of the Fluconazole Resistance of Candida Albicans

Synergistic Effects of Tetrandrine with Posaconazole Against Aspergillus Fumigatus.

In vitro activity of terbinafine in combinations with other antifungi drugs against clinical pathogenic fungi of vulvovaginal candidiasis

An in Vitro and in Vivo Study on the Synergistic Effect and Mechanism of Itraconazole or Voriconazole Alone and in Combination with Tetrandrine Against Aspergillus Fumigatus.

Detection of in vitro anti-fungal activity of 20 tetralin compounds

Effect Of Tetrandrine Against Candida Albicans Biofilms

Activities of Terbinafine in Combination with Itraconazole and Fluconazole Against Isolates of Candida albicans In Vitro

In vitro interaction between fluconazole and triclosan against clinical isolates of fluconazole-resistant Candida albicans determined by different methods.